Fulgent Genetics, Inc. (FLGT): Capital Expenditures
$22.57M
Year ended 2025-12-31
$20.09M
Trailing 12 months to 2026-06-30
+6.3%
3-year compound annual growth
-8.5%
5-year compound annual growth
+26.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.57M | -44.0% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $40.31M | +81.5% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $22.21M | +18.3% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $18.77M | -21.2% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $23.81M | -32.2% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $35.13M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $1.18M | -49.1% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $2.32M | -19.8% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $2.90M | -23.6% | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $3.79M | +80.4% | 2018-03-20, From 2016-01-01 |
| 2015-12-31 | $2.10M | +187.3% | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | $731.0K | n/a | 2017-03-17, From 2014-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $8.88M | +64.4% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $9.68M | -14.3% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $909.0K | -82.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $16.26M | +92.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $48.31M | +37.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | $259.0K | -92.0% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $4.50M | +181.0% |
Compare FLGT, BLLN, CSTL, VCYT side by side · Screen every company in Services-Medical Laboratories ↗